NCT06954376

Brief Summary

This research aimed to investigate the effectiveness of hyperbaric oxygen therapy as a neuroprotective strategy for improving neurological outcomes in pediatric patients who have sustained acquired brain injury.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 24, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 1, 2025

Completed
Last Updated

May 1, 2025

Status Verified

April 1, 2025

Enrollment Period

7 months

First QC Date

April 24, 2025

Last Update Submit

April 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Communication Function Classification System

    The Communication Function Classification System (CFCS) was implemented to assess cognitive and speech capabilities across five levels of communicative competence. * Level I: Effective bidirectional communication (no need for external aids). * Level II: Consistent communication with familiar partners, occasional need for aids. * Level III: Communication requires significant effort and aids with familiar partners. * Level IV: Minimal communication, even with familiar partners. * Level V: No effective communication.

    Eight months post-intervention

Secondary Outcomes (2)

  • Nutritional intake functionality

    Eight months post-intervention

  • Visual function assessment

    Eight months post-intervention

Study Arms (2)

Hyperbaric oxygen therapy group

EXPERIMENTAL

Patients received hyperbaric oxygen therapy (HBOT) using a monochamber hyperbaric chamber in addition to conventional rehabilitation.

Other: Hyperbaric oxygen therapy

Control group

ACTIVE COMPARATOR

Patients received conventional rehabilitation alone.

Other: Conventional rehabilitation

Interventions

Patients received hyperbaric oxygen therapy (HBOT) using a monochamber hyperbaric chamber in addition to conventional rehabilitation.

Hyperbaric oxygen therapy group

Patients received conventional rehabilitation alone.

Control group

Eligibility Criteria

Age4 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Pediatric patients aged 4-12 years with acquired brain injury.
  • Confirmed neurological sequelae (e.g., cardiac arrest, intracranial hemorrhage, central nervous system infections, stroke, tumor, hypoxia) via MRI/neurological exam.

You may not qualify if:

  • Positive family history of degenerative brain insults.
  • Behavioral problems.
  • Hyperbaric oxygen therapy contraindications:
  • Active epilepsy.
  • Respiratory insufficiency.
  • Uncontrolled heart failure.
  • Eustachian tube dysfunction.
  • Tympanic membrane rupture.
  • Mechanical ventilation dependency.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kafrelsheikh University

Kafr ash Shaykh, Kafrelsheikh, 33516, Egypt

Location

MeSH Terms

Conditions

Brain Injuries

Interventions

Hyperbaric Oxygenation

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Oxygen Inhalation TherapyRespiratory TherapyTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer of Pediatrics, Faculty of Medicine, Kafr Elsheikh University, Kafr Elsheikh, Egypt.

Study Record Dates

First Submitted

April 24, 2025

First Posted

May 1, 2025

Study Start

March 1, 2024

Primary Completion

October 1, 2024

Study Completion

October 1, 2024

Last Updated

May 1, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations